Pages that link to "Q40913054"
Jump to navigation
Jump to search
The following pages link to Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease (Q40913054):
Displaying 50 items.
- Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function (Q24563622) (← links)
- Regression of atherosclerosis: insights from animal and clinical studies (Q27028112) (← links)
- Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective (Q28195433) (← links)
- The associations between serum biomarkers and stenosis of the coronary arteries (Q28554584) (← links)
- Expression of tissue transglutaminase and elafin in human coronary artery (Q29036003) (← links)
- Ameliorative potential of Coccinia grandis extract on serum and liver marker enzymes and lipid profile in streptozotocin induced diabetic rats. (Q30418585) (← links)
- Making practical sense of clinical trial data in decreasing cardiovascular risk (Q30659167) (← links)
- HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data (Q32050110) (← links)
- Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins (Q32062993) (← links)
- The gender specific frequency of risk factor and CHD diagnoses prior to incident MI: a community study (Q33281123) (← links)
- Cholesterol lowering and coronary artery disease: mechanisms of risk reduction. (Q33538129) (← links)
- Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications (Q33585657) (← links)
- Regression of atherosclerosis--an ounce of prevention. (Q33607199) (← links)
- Coronary atherosclerosis and interventions: pathological sequences and restenosis (Q33655853) (← links)
- Best practice--ongoing polemics (Q33670420) (← links)
- Plaque disruption and thrombosis. Potential role of inflammation and infection (Q33671913) (← links)
- Cholesterol lowering and endothelial function (Q33777699) (← links)
- Screening for cardiovascular disease. Concepts, conflicts, and consensus (Q33786237) (← links)
- Management of hyperlipidaemia after coronary revascularisation: follow up study (Q33791383) (← links)
- Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study (Q33808498) (← links)
- Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke (Q33815841) (← links)
- The evolving role of statins in the management of atherosclerosis (Q33818141) (← links)
- New insights into the pharmacodynamic and pharmacokinetic properties of statins. (Q33832848) (← links)
- Cholesterol management in the era of managed care (Q33850673) (← links)
- Non-lipid-related effects of statins (Q33924588) (← links)
- Types of dietary fat and risk of coronary heart disease: a critical review (Q33941776) (← links)
- Lipid lowering improves endothelial functions (Q33944796) (← links)
- Risk factor modification through nonpharmacological interventions in patients with coronary heart disease (Q33958380) (← links)
- The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients (Q33996158) (← links)
- PPAR agonists as direct modulators of the vessel wall in cardiovascular disease (Q33996831) (← links)
- Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment (Q34003407) (← links)
- Imaging techniques to predict cardiovascular risk. (Q34011185) (← links)
- Rationale for a postintervention continuum of care: insights from intravascular ultrasound (Q34054441) (← links)
- Is hypercholesterolemia a risk factor and should it be treated in the elderly? (Q34077942) (← links)
- Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization (Q34084203) (← links)
- Role of plaque rupture in acute coronary syndromes (Q34084212) (← links)
- Combination drug therapy for dyslipidemia. (Q34107165) (← links)
- Percutaneous coronary intervention versus medical therapy for coronary heart disease (Q34107464) (← links)
- Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound (Q34131865) (← links)
- Coronary angiography and intravascular ultrasound (Q34177759) (← links)
- Mechanisms of acute coronary syndromes and the potential role of statins (Q34207179) (← links)
- Effectiveness of statins in acute coronary syndromes (Q34345273) (← links)
- Mechanisms of plaque stabilization for a charged calcium channel blocker in coronary artery disease (Q34371511) (← links)
- Physical activity and exercise training prescriptions for patients (Q34379597) (← links)
- Design and conduct of clinical trials in hormone replacement therapy (Q34397332) (← links)
- Mechanisms of atherosclerotic plaque stabilization for a lipophilic calcium antagonist amlodipine (Q34436532) (← links)
- Effect of lipid-lowering agents, angiotensin-converting enzyme inhibitors, and calcium antagonists on coronary disease risk (Q34436546) (← links)
- The role of risk factors in the development of atherosclerosis (Q34447107) (← links)
- The Anti-Ischemic and Anti-Anginal Properties of Statins (Q34477330) (← links)
- Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors (Q34556386) (← links)